Inovio announces effective date of 1-for-12 reverse stock split

Plymouth meeting, pa. , jan. 23, 2024 /prnewswire/ -- inovio (nasdaq:ino), a biotechnology company focused on developing and commercializing dna medicines to help treat and protect people from hpv-related diseases, cancer and infectious diseases, today announced that a 1-for-12 reverse stock split of its outstanding shares of common stock will be effective as of 5:00 p.m.
INO Ratings Summary
INO Quant Ranking